Clinical Trials Browser

Observational × Atrial Fibrillation × Other hematologic neoplasm × Clear all

Arrhythmias, Cardiac, Atrial Fibrillation, Leukemia, Lymphocytic, Chronic, B-Cell, Death, Sudden, Cardiac, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT06211413 2026-03-23

SENTINEL

Enrolling by invitation

50 enrolled

LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Cardiotoxicity

NCT06224452 2024-03-05

Is Ibrutinib-related Atrial Fibrillation Dose Dependent

Unknown

18,000 enrolled

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms

NCT06130709 2023-11-14

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

Unknown

100 enrolled

Other hematologic neoplasm

Atrial Fibrillation, Hematologic Neoplasms

NCT04407845 2020-06-09

FABRIC

Unknown

60 enrolled

LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Clinical Trials

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

SENTINEL

Is Ibrutinib-related Atrial Fibrillation Dose Dependent

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

FABRIC